搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
1 小时
I'm a male celebrity on Ozempic. I didn't even need it - but easy weight loss was too ...
Recently, an anonymous female celebrity spoke about why she turned to Ozempic. This inspired another public figure - this ...
The Cincinnati Herald
22 小时
Weight loss plans often miss black women
Healthy diet and regular exercise are key to treating obesity. But the stress of everyday racism and sexism hinder Black women from adopting lifestyle changes necessary for weight loss.
1 天
Mounjaro and Wegovy fact and fiction as experts reveal six things you must know about ...
Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...
Futurism on MSN
2 天
Mounjaro Appears to Be Extremely Effective at Preventing Diabetes
A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...
2 天
on MSN
RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...
2 天
5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
2 天
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
2 天
The Best Options for Online Weight Loss Prescriptions in 2024
The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.
News Medical
3 天
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and ...
Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
verywellhealth
3 天
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
3 天
Teens Are Being Prescribed Wegovy and GLP-1s at Record Rates. Should Parents Be Worried?
In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...
3 天
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's ...
Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈